BRASILIA. KAZINFORM - Brazil’s drug authority Anvisa has approved the registration of a new vaccine against dengue fever. Qdenga, produced by Takeda Pharma, is indicated for people aged four through 60. Its administration is subcutaneous, in a scheme of two doses with a three-month interval, Agencia Brasil reports.
Related Keywords
Brazil , Brasilia , Distrito Federal , Takeda Pharma , Agencia Brasil , National Technical Commission On Biosafety Ctnbio , European Health Agency , National Technical Commission , European Health , Dengue , Vaccine , Approved ,
comparemela.com © 2020. All Rights Reserved.